Some Bullish Stocks Overview (CG, SWI, DK, ARIA)

Los Angelas, CA -- (SBWIRE) -- 09/05/2012 -- The Carlyle Group (NasdaqNM:CG) are trading at $26.28 and is +7.36% from its 50-day Moving Average price of $24.478 and +14.78% from its 200-day Moving Average price of $22.8955. The average trading volume is 179662 shares and its market capitalization is $1.136B. The business is expected to generate $4 billion in sales this year and employs more than 11,000 employees in 35 plants throughout the world. DPC is a maker of automotive paints and related products with 43% of their sales going to auto repair shops.

Get Your Free Copy Today Click Here

Solarwinds, Inc. (NYSE:SWI) reported EPS of 0.979. For the Current Fiscal year, the company is expected to report EPS of 1.25. For the Next Quarter and Next Year, the company is expected to report EPS of 0.31 and 1.47 respectively. At Current Market Price, SWI is in distance of +11.60% from its 50-day Moving Average price of $52.5246 and +31.88% from its 200-day Moving Average price of $44.4482.SolarWinds hit a new 52-week high Tuesday as it is currently trading at $58.62, above its previous 52-week high of $56.94 with 222,730 shares traded.SolarWinds has a market cap of $4.07 billion and is part of the technology sector and computer software & services industry.

Need Free Updates Via Email Click Here

Delek US Holdings (NYSE:DK) are trading at $27.39 and is +20.60% from its 50-day Moving Average price of $22.7117 and +56.01% from its 200-day Moving Average price of $17.557. The average trading volume is 446831 shares and its market capitalization is $1.604B. The Group sold 5.15% of shares in Delek US for NIS 285 million, generating an expected profit of NIS 134 million that will be recorded as an increase in shareholders equity in Q3 2012. The Group announced a dividend of NIS 80 million for the first six months of 2012.

Need Free Updates Via Email Click Here

ARIAD Pharmaceuti (NasdaqNM:ARIA) reported EPS of -0.975. For the Current Fiscal year, the company is expected to report EPS of -1.32. For the Next Quarter and Next Year, the company is expected to report EPS of -0.36 and -1.23 respectively. At Current Market Price, ARIA is in distance of +10.90% from its 50-day Moving Average price of $19.1786 and +25.60% from its 200-day Moving Average price of $16.9353. Ariad Pharmaceuticals hit a new 52-week high Tuesday as it is currently trading at $20.79, above its previous 52-week high of $20.68 with 50,063 shares traded as of 9:40 a.m. ET. Average volume has been 2.5 million shares over the past 30 days.

To know its future just click here

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com